王荣,任宁君,李爱玲,等.2016—2022年四川省泸州市肝癌发病的变化趋势[J].上海预防医学,2024,36(1):47-52.. doi: 10.19428/j.cnki.sjpm.2024.23334
引用本文: 王荣,任宁君,李爱玲,等.2016—2022年四川省泸州市肝癌发病的变化趋势[J].上海预防医学,2024,36(1):47-52.. doi: 10.19428/j.cnki.sjpm.2024.23334
WANG Rong,REN Ningjun,LI Ailing,et al.Epidemiological trend analysis of liver cancer incidence in Luzhou City, Sichuan Province from 2016 to 2022[J].Shanghai Journal of Preventive Medicine,2024,36(01):47-52.. doi: 10.19428/j.cnki.sjpm.2024.23334
Citation: WANG Rong,REN Ningjun,LI Ailing,et al.Epidemiological trend analysis of liver cancer incidence in Luzhou City, Sichuan Province from 2016 to 2022[J].Shanghai Journal of Preventive Medicine,2024,36(01):47-52.. doi: 10.19428/j.cnki.sjpm.2024.23334

20162022年四川省泸州市肝癌发病的变化趋势

Epidemiological trend analysis of liver cancer incidence in Luzhou City, Sichuan Province from 2016 to 2022

  • 摘要:
    目的 分析2016—2022年四川省泸州市居民肝癌发病的流行病学分布及时间变化趋势,为完善泸州市肝癌防治策略提供理论基础。
    方法 收集泸州市2016—2022年居民肝癌发病数据,计算肝癌发病率、年龄别发病率以及年度变化百分比(APC),并运用Joinpoint回归模型对泸州市各区县每月新增病例数进行时间序列分段拟合,分析肝癌发病率的变化趋势。
    结果 泸州市肝癌发病率由2016年的22.96/10万上升至2022年的32.31/10万。2016—2022年男性肝癌发病率均高于女性,男性肝癌发病率由2016年的34.83/10万上升至2022年的47.95/10万,APC为3.3%;女性肝癌发病率由2016年的10.50/10万上升至2022年的15.95/10万,APC为3.0%,变化趋势差异无统计学意义(P>0.05)。2016—2022年0~<40岁年龄组肝癌发病率较低,随着年龄的增长肝癌发病率上升;55~岁年龄组肝癌发病率以年均16.4%的幅度上升。
    结论 泸州市肝癌发病率整体呈上升趋势,男性肝癌发病率高于女性。中老年男性是肝癌防治的重点人群,应结合地区发展差异,针对性地开展肝癌防治工作。

     

    Abstract:
    Objective To analyze the epidemiological distribution and temporal trends of liver cancer incidence among Luzhou residents from 2016‒2022, and to provide a theoretical basis for improving liver cancer prevention and treatment strategies in Luzhou.
    Methods Data on liver cancer incidence among Luzhou residents from 2016 to 2022 were collected, and the incidence rate, age-specific incidence rate, and annual percentage change (APC) were calculated. A Joinpoint regression model was used to fit a time series segment to the monthly number of new cases in each district and county of Luzhou to explore the trend of liver cancer incidence rate.
    Results The incidence rate of liver cancer in Luzhou increased from 22.96/105 in 2016 to 32.31/105 in 2022. The incidence rate of liver cancer in men was higher than that in women in both 2016 and 2022, and the incidence rate of liver cancer in men increased from 34.83/105 in 2016 to 47.95/105 in 2022, with an APC of 3.3%; the incidence rate of liver cancer in women increased from 10.50/105 in 2016 to 15.95/105 in 2022, with an APC of 3.0%, and the differences in the change trends were not statistically significant (P>0.05).The incidence of liver cancer was low in the age group of 0‒<40 years from 2016 to 2022 and increased with age; the incidence of liver cancer in the age group of 55 years and above was increasing at an average annual rate of 16.4%.
    Conclusion The overall incidence of liver cancer in Luzhou is on the rise, and the incidence of liver cancer in men is higher than that in women. Middle-aged and elderly men are the key population for liver cancer prevention and treatment, and liver cancer prevention and treatment should be carried out in a targeted manner, taking into account regional development differences.

     

/

返回文章
返回